Co-Authors
This is a "connection" page, showing publications co-authored by Mohammad Varahram and Payam Tabarsi.
Connection Strength
0.946
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.224
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.221
-
Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
Score: 0.059
-
COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol. 2021; 11:563085.
Score: 0.058
-
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
Score: 0.058
-
Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299.
Score: 0.057
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
Score: 0.057
-
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128.
Score: 0.057
-
The Immune Response and Immunopathology of COVID-19. Front Immunol. 2020; 11:2037.
Score: 0.056
-
Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis. Dis Markers. 2019; 2019:1907426.
Score: 0.051
-
miR-1224 Expression Is Increased in Human Macrophages after Infection with Bacillus Calmette-Guérin (BCG). Iran J Allergy Asthma Immunol. 2018 Jun; 17(3):250-257.
Score: 0.048